BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7721113)

  • 1. Detection and treatment of hypothyroidism and Graves' disease.
    Hurley DL; Gharib H
    Geriatrics; 1995 Apr; 50(4):41-4. PubMed ID: 7721113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
    Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
    Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pregnancy and the thyroid gland].
    Lieutaud H
    Ann Med Interne (Paris); 1999 Sep; 150(5):397-407. PubMed ID: 10544750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypothyroidism and endocrine orbitopathy].
    Wiesli P; Knierim M; Knierim C; Schmid C
    Praxis (Bern 1994); 2000 Oct; 89(40):1612-5. PubMed ID: 11081360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism.
    Baskin HJ; Cobin RH; Duick DS; Gharib H; Guttler RB; Kaplan MM; Segal RL;
    Endocr Pract; 2002; 8(6):457-69. PubMed ID: 15260011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioactive iodine therapy in Graves' hyperthyroidism.
    Sankar R; Sripathy G
    Natl Med J India; 2000; 13(5):246-51. PubMed ID: 11190053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The interpretation of the thyroid stimulating hormone (TSH) assay].
    Wiersinga WM
    Ned Tijdschr Geneeskd; 2003 Jun; 147(24):1156-8. PubMed ID: 12845833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thyroid dysfunction in the aged].
    Marañón Cabello A
    An Med Interna; 2000 Jan; 17(1):1-4. PubMed ID: 10730396
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical significance of thyrotropin measurement by immunoradiometric assay and thyrotropin-releasing hormone test].
    Luo GC
    Zhonghua Yi Xue Za Zhi; 1993 Jun; 73(6):355-7, 382. PubMed ID: 8258107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Problems and new developments in the management of Graves' disease: medical therapy].
    Quadbeck B; Janssen OE; Mann K
    Z Arztl Fortbild Qualitatssich; 2004 May; 98 Suppl 5():37-44. PubMed ID: 15255312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graves' hyperthyroidism following primary hypothyroidism due to Hashimoto's thyroiditis in a case of thyroid hemiagenesis: case report.
    Ruchała M; Szczepanek E; Skiba A; Czepczyński R; Sowiński J
    Neuro Endocrinol Lett; 2008 Feb; 29(1):55-8. PubMed ID: 18283259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy insight: management of Graves' disease during pregnancy.
    Chan GW; Mandel SJ
    Nat Clin Pract Endocrinol Metab; 2007 Jun; 3(6):470-8. PubMed ID: 17515891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of overt and subclinical hypothyroidism. Factors influencing L-thyroxine dosage.
    Rezzónico JN; Pusiol E; Saravi FD; Rezzónico M; Bossa N
    Medicina (B Aires); 1999; 59(6):698-704. PubMed ID: 10752211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.